ORGO
Organogenesis Holdings Inc. Healthcare - Drug Manufacturers - Specialty & Generic Investor Relations →
Organogenesis Holdings Inc. (ORGO) closed at $3.77 as of 2026-02-02, trading 4.5% above its 200-week moving average of $3.61. The stock is currently moving closer to the line, down from 10.2% last week. The 14-week RSI sits at 46, indicating neutral momentum.
Over the past 426 weeks of data, ORGO has crossed below its 200-week moving average 6 times. On average, these episodes lasted 50 weeks. The average one-year return after crossing below was -30.8%, suggesting these dips have not historically been reliable buying opportunities for this stock.
With a market cap of $478 million, ORGO is a small-cap stock. Free cash flow yield is currently negative, meaning the company is burning cash. Return on equity stands at 0.3%. The stock trades at 1.9x book value.
Over the past 8.2 years, a hypothetical investment of $100 in ORGO would have grown to $38, compared to $295 for the S&P 500. ORGO has returned -11.1% annualized vs 14.0% for the index, underperforming the broader market over this period.
In the past 12 months, corporate insiders have made 2 open-market purchases totaling $1,821,329.
Free cash flow has been declining at a -48.6% compound annual rate. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.
Growth of $100: ORGO vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After ORGO Crosses Below the Line?
Across 6 historical episodes, buying ORGO when it crossed below its 200-week moving average produced an average return of -32.3% after 12 months (median -26.0%), compared to +4.3% for the S&P 500 over the same periods. 17% of those episodes were profitable after one year. After 24 months, the average return was -34.3% vs +20.3% for the index.
Each line shows $100 invested at the moment ORGO crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
ORGO has crossed below its 200-week MA 6 times with an average 1-year return of +-30.8% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Dec 2017 | Dec 2017 | 2 | 0.6% | +3.3% | -61.6% |
| Feb 2018 | Mar 2018 | 3 | 0.0% | -20.8% | -61.9% |
| Apr 2018 | Apr 2018 | 1 | 0.1% | -14.8% | -61.9% |
| Oct 2018 | Oct 2018 | 1 | 1.5% | -27.0% | -61.5% |
| Feb 2019 | Jan 2021 | 101 | 69.2% | -54.0% | -63.1% |
| Nov 2021 | Jul 2025 | 189 | 74.5% | -71.5% | -60.5% |
| Average | 50 | — | +-30.8% | — |
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of Friday close, 2026-02-02